Reactions 1704, p33 - 2 Jun 2018 Injection site reactions: case report A 78-year-old woman developed injection site reactions during treatment of chronic calcium pyrophosphate arthritis with anakinra [duration of treatment to reaction onset and outcome not stated]. The woman had microscopically proven chronic calcium pyrophosphate arthritis for 10 years. She was initially treated with colchicine and prednisone, but no improvement was noted. Mild response was noted with methotrexate therapy, but it was discontinued due to unspecified adverse events. Thereafter, her treatment was started with SC anakinra 100 mg/day. Initially, a good response was noted, but later she developed injection site reactions. Her anakinra treatment was stopped and tocilizumab was started for her underlying condition. Her arthritis subsided with a significantly reduced joint pain and normalisation of acute phase reactants without any adverse events. Author comment: "[A]nakinra at 100 mg/day subcutaneously was initiated. She initially reported a good response, but the drug was later stopped due to injection site reactions." Quilis N, et al. Interleukin-6 pathway blockade as an option for managing refractory cases of crystal arthritis: Two cases report. Joint Bone Spine 85: 377-378, No. 3, May 2018. Available from: URL: http://doi.org/10.1016/ j.jbspin.2017.04.008 - Spain 803323654 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera